Corridor Pharmaceuticals Mergers and Acquisitions Summary

Life ScienceCompany

Corridor Pharmaceuticals has acquired 1 company. A total of 1 acquisition came from private equity firms.

Corridor Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Join Mergr and gain access to Corridor Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Corridor Pharmaceuticals, Inc.

2330 West Joppa Road Suite 330,
Lutherville, Maryland 21093
United States,
www.corridorpharma.com

Corridor Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics for pulmonary arterial hypertension (PAH) and other vascular diseases based on its proprietary serotonin antagonist and arginase inhibition platforms.


M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Immune Control 2010-06-17 - Merger
West Conshohocken, Pennsylvania · www.immunecontrol.com/
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  Pennsylvania 1 - - -
Total 1 - - -

M&A Connections

Deals
Acquired from
Investor(s)
100%
1 (100%)

 Subscribe to unlock this and 181,586
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.3K Private Equity Firms
  • 172K M&A Transactions
  • 177K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 63K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.